Short-Term Debt to Capital: KORU Medical Systems (KRMD)

KORU Medical Systems (KRMD) maintains its status as a reputable provider of home subcutaneous injection systems, offering comfort and autonomy to patients with chronic pathologies. This price chart confirms the financial standing, where the indicator is 0.02. The technological process relies on automated sterile facilities featuring video quality control. The monetization model is based on the sale of premium consumables, creating a sustainable consumer dependence on the brand.

A conservative investor views this ratio as a marker of liquidity and financial stability. This is critical for KORU Medical Systems (KRMD), as the vulnerability of biopharmaceutical supply chains necessitates the maintenance of reserves. By analyzing the change in short-term debt relative to equity, we observe the proportion of current liabilities to net assets. The stability of this metric confirms a balanced financing strategy without the risk of a sudden default.